Vitamin B6 and Cancer Risk: A Field Synopsis and Meta-Analysis

Background Vitamin B6 is involved in many biochemical reactions and might play a role in carcinogenesis. We summarized the evidence linking vitamin B6 to cancer risk. Methods We conducted a systematic review of both observational and intervention studies investigating the relationship between vitamin B6 intake or blood levels of its bioactive form pyridoxal-5'-phosphate (PLP) and the risk of any type of cancer. Random-effects meta-analysis was used to calculate pooled relative risks (RRs) and their 95% confidence intervals (CIs) across studies for high vs low categories of vitamin intake or PLP levels. We also performed a random-effects dose-response meta-analysis. Results We identified 121 observational studies (participants, n = 1 924 506; cases, n = 96 , 436) and nine randomized controlled trials (RCTs; participants, n = 34 911; cases, n = 2539) considering 19 tumor sites. High intake of dietary (food only) vitamin B6 was statistically significantly associated with lower risk of all cancers (relative risk [RR] = 0.78, 95% CI = 0.73 to 0.84) and specific tumors, with special regard to gastrointestinal carcinomas (RR = 0.68, 95% CI = 0.61 to 0.75). An inverse association was also observed between high PLP levels and the risk of all cancers (RR = 0.66, 95% CI = 0.58 to 0.76) and single tumor sites, the most consistent results being those for gastrointestinal tumors (RR = 0.56, 95% CI = 0.48 to 0.65). There was a statistically significant inverse linear relationship between cancer risk and both vitamin B6 dietary intake and PLP levels. When total (food and supplements) intake was considered, the associations were weaker or null. Findings from RCTs did not support a protective effect of vitamin B6 against cancer, although this evidence was graded as low level. Conclusions Epidemiological evidence supports the potential of vitamin B6 as a cancer risk reduction agent and the role of PLP as a cancer screening biomarker, especially for gastrointestinal tumors. However, inconsistent findings from total intake and intervention studies suggest that vitamin B6 might also be an indicator of other dietary protective micronutrients.

[1]  Zhimin Zhang,et al.  One-Carbon Metabolic Factors and Risk of Renal Cell Cancer: A Meta-Analysis , 2015, PloS one.

[2]  D. Jiao,et al.  Association of methylenetetrahydrofolate reductase and methionine synthase polymorphisms with breast cancer risk and interaction with folate, vitamin B6, and vitamin B12 intakes , 2014, Tumor Biology.

[3]  M. Gatti,et al.  Sugar and Chromosome Stability: Clastogenic Effects of Sugars in Vitamin B6-Deficient Cells , 2014, PLoS genetics.

[4]  L. Villa,et al.  Polymorphisms in genes involved in folate metabolism modify the association of dietary and circulating folate and vitamin B-6 with cervical neoplasia. , 2013, The Journal of nutrition.

[5]  L. Galluzzi,et al.  Effects of vitamin B6 metabolism on oncogenesis, tumor progression and therapeutic responses , 2013, Oncogene.

[6]  N. Rothman,et al.  Role of one-carbon metabolizing pathway genes and gene–nutrient interaction in the risk of non-Hodgkin lymphoma , 2013, Cancer Causes & Control.

[7]  Dongfeng Zhang,et al.  Association of vitamin B6, vitamin B12 and methionine with risk of breast cancer: a dose–response meta-analysis , 2013, British Journal of Cancer.

[8]  B. Rosner,et al.  One-carbon metabolism factors and endometrial cancer risk , 2013, British Journal of Cancer.

[9]  J. Sterne,et al.  The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials , 2011, BMJ : British Medical Journal.

[10]  Giu-Cheng Hsu,et al.  Dietary Intake of Vitamin B6 and Risk of Breast Cancer in Taiwanese Women , 2011, Journal of epidemiology.

[11]  F. Clavel-Chapelon,et al.  Plasma Vitamins B2, B6, and B12, and Related Genetic Variants as Predictors of Colorectal Cancer Risk , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[12]  Nicola Orsini,et al.  Vitamin B6 and risk of colorectal cancer: a meta-analysis of prospective studies. , 2010, JAMA.

[13]  S. Vollset,et al.  Cancer incidence and mortality after treatment with folic acid and vitamin B12. , 2009, JAMA.

[14]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement , 2009, BMJ.

[15]  R. Goldbohm,et al.  Dietary folate, methionine, riboflavin, and vitamin B-6 and risk of sporadic colorectal cancer. , 2008, The Journal of nutrition.

[16]  J. Manson,et al.  Effect of combined folic acid, vitamin B6, and vitamin B12 on cancer risk in women: a randomized trial. , 2008, JAMA.

[17]  D. Albanes,et al.  One-Carbon Metabolism Biomarkers and Risk of Colon and Rectal Cancers , 2008, Cancer Epidemiology Biomarkers & Prevention.

[18]  G. Guyatt,et al.  GRADE: an emerging consensus on rating quality of evidence and strength of recommendations , 2008, BMJ : British Medical Journal.

[19]  W. Willett,et al.  Folate, Vitamin B6, and Vitamin B12 Intake and the Risk of Breast Cancer Among Mexican Women , 2006, Cancer Epidemiology Biomarkers & Prevention.

[20]  L. Chambless,et al.  Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. , 2004, JAMA.

[21]  K. Matsubara,et al.  Antitumor effect of vitamin B6 and its mechanisms. , 2003, Biochimica et biophysica acta.

[22]  B. Ames,et al.  Are vitamin and mineral deficiencies a major cancer risk? , 2002, Nature Reviews Cancer.

[23]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[24]  B. Ames,et al.  DNA damage from micronutrient deficiencies is likely to be a major cause of cancer. , 2001, Mutation research.

[25]  I. Olkin,et al.  Meta-analysis of observational studies in epidemiology - A proposal for reporting , 2000 .

[26]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[27]  S. Greenland,et al.  Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. , 1992, American journal of epidemiology.

[28]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[29]  P. Tugwell,et al.  The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses , 2014 .

[30]  Jun Zhang,et al.  Vitamin and multiple-vitamin supplement intake and incidence of colorectal cancer: a meta-analysis of cohort studies , 2014, Medical Oncology.

[31]  G. Wondrak,et al.  Vitamin B6: beyond coenzyme functions. , 2012, Sub-cellular biochemistry.

[32]  Nicola Orsini,et al.  Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. , 2012, American journal of epidemiology.

[33]  J. Selhub.  Folate, vitamin B12 and vitamin B6 and one carbon metabolism. , 2002, The journal of nutrition, health & aging.